Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q3 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $12.81 million versus the consensus estimate of $12.7 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.